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Insulin resistance and coronary artery disease in non-diabetic 
patients: Is there any correlation? 
   
 
Abstract 
Background: Cardiovascular diseases are the most common causes of death in the world 
and type 2 diabetes is one of them because it is highly prevalent and doubles heart disease 
risk. Some studies suggest that insulin resistance is associated with coronary artery disease 
in non-diabetics. The aim of this study was to evaluate the association of insulin resistance 
(IR) and coronary artery disease (CAD) in non-diabetic patients. 
Methods: In this cross-sectional study, from September 2014 to July 2015, 120 patients 
referring to Shahid Beheshti Hospital of Qom were evaluated. Their medical history, 
baseline laboratory studies, BMI and GFR were recorded. After 8 hours of fasting, blood 
samples were taken from the patients at 8 am, including fasting glucose and insulin level. 
We estimated insulin resistance using the homeostatic model assessment index of IR 
(HOMA-IR). Finally, we evaluated the association between IR and CAD. 
Results: Totally, 120 patients were assigned to participate in this study, among them, 50 
patients without CAD and 70 with coronary artery stenosis. Insulin resistance (HOMA-
IR> 2.5) was positive in 59 (49.3%) patients and negative in 61 (50.7%) patients. Hence, 
the correlation between IR and CAD was not statistically significant (P=0.9). 
Conclusions: In this study, although the correlation was not found between insulin 
resistance and coronary heart disease, among men, we found a significant association 
between coronary heart disease and insulin resistance. 
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Cardiovascular diseases are the most common causes of death in the world (1) and 
type 2 diabetes is one of them because it is highly prevalent and doubles heart disease risk 
(2, 3). Accordingly, studies have shown that increased glucose and insulin concentrations 
can be pro-atherogenic (4, 5). Since all type 2 diabetic patients are insulin resistant, it is 
difficult to assess its role in the development of coronary artery disease of diabetics. Based 
on animal studies, insulin resistance is exclusively involved in the early and advanced 
stages of atherosclerosis, and hyperglycemia plays an important role in the early stages of 
atherosclerosis (6). In addition, it seems that insulin resistance modifies the effect of 
insulin on the vascular wall and has anti-atherogenic effect in the insulin sensitive state 
and pro-atherogenic effect in the insulin resistant state (5). Also, some studies showed that 
among those with type one diabetes who have higher rates of insulin resistance, the risk of 
coronary disease is higher (7, 8); so, the question is apart from changes in serum glucose 
level, does increased insulin resistance play a role in the development of atherosclerosis 
independently? High insulin and glucose concentrations are direct consequences of insulin 
resistance. Insulin resistance can promote the development of atherosclerosis through 
increased glucose and insulin concentrations and also mechanisms that involve 
dyslipidemia, hypertension, and inflammation (4, 6). 
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Furthermore, procoagulant state inflammation, 
endothelial dysfunction, hyperuricemia, enhanced 
sympathetic, nervous system activity, increased renal tubular 
sodium reabsorption, increased incidence of obesity and 
acute phase proteins, changes in adiponectin levels, 
interference in the synthesis of NO are the other contributing 
factors (9-12). Therefore, cardiovascular diseases may be a 
consequence of insulin resistance rather than being caused 
by toxic effects of high insulin or glucose concentrations. 
Homeostasis model assessment insulin resistance (HOMA-
IR) is a validated and commonly used marker of insulin 
resistance which incorporates both glucose and insulin 
concentrations and represents insulin resistance that can 
promote atherosclerosis through several mechanisms (4, 6). 
Some studies suggest that insulin resistance is associated 
with coronary artery disease in non-diabetic subjects (9, 13). 
This relationship is interesting because insulin resistance is 
increasing nowadays and if the studies prove the association 
between IR and CAD, medication and lifestyle changes will 
decrease insulin resistance, then coronary artery disease can 
be prevented. The aim of this study was to evaluate insulin 
resistance and coronary artery disease in non-diabetic 
patients. 
 
 
Methods 
Patients: This cross-sectional study was performed from 
September 2014 to July 2015. The inclusion criteria were: 
patients who were candidates for coronary angiography in 
the catheter Lab of Shahid Beheshti Hospital of Qom 
University of Medical Sciences. From all of the subjects, 
their medical history was obtained and recorded, body mass 
index (BMI) was calculated as weight in kilograms divided 
by the square of the height in meters (kg/m2) and blood 
samples were taken for laboratory to be studied. 
Patients with history of CHD or prior coronary 
revascularization, heart failure or any type of 
cardiomyopathy, familial hypercholesterolemia, impaired 
liver or renal function, anemia, malignancy and diabetes 
were excluded from the study. 
Laboratory studies and the assessment of insulin 
resistance: After an 8-hour fasting, blood samples were 
taken from the patients at 8 am, including fasting glucose, 
insulin concentration, CBC, liver function tests, lipid profile, 
BUN and creatinine. All parameters were evaluated in the 
hospital laboratory. We estimated insulin resistance using the 
homeostatic model assessment index of IR (HOMA-IR) 
developed by Mathew with the following formula: HOMA-
IR = baseline insulin concentration (mU/L)×baseline glucose 
concentration (mg/dL)/405 (14). 
Coronary angiography: Coronary angiography was 
performed by femoral artery using Judkins method (15). 
Two experienced cardiologists unaware of the patients’ 
enrollment reviewed all angiograms. If they did not have the 
same view, the third cardiologist would see the angiographic 
film and then, based on angiographic results, patients were 
divided into two groups with and without coronary artery 
disease. Coronary artery disease was defined as more than 
50% luminal diameter stenosis of at least one coronary 
artery. Patients with CAD were divided into two groups, 
single and multi-vessel disease (SVD and MVD). Patients 
without CAD were divided in two subgroups,group one had 
luminal diameter narrowing <50% and considered as 
minimal coronary artery disease (MCAD) and group 2 
without luminal narrowing considered as normal. 
Statistical analysis: Chi-square test was used for comparing 
between categorical data and correlation between them. 
These data are presented as numbers (percentages).We 
applied student's t-test to compare the continuous variables 
and were expressed as mean±SD. Differences between more 
than two groups were tested with one-way ANOVA. We also 
used multivariate logistic regression to control the 
confounding factors that were effective on the relationships 
between IR and CAD. Finally, we analyzed the data using 
SPSS 16.0, and a p-value less than 0.05 was considered 
statistically significant. 
Ethics: All individuals signed informed consent prior to 
their enrollment in the study. Also, the study was planned 
according to the ethical guidelines of the Declaration of 
Helsinki and the approval of Ethics Committee of Qom 
University of Medical Sciences. 
 
 
Results 
In this study, 50 patients were assigned to group without 
CAD, 16 (13.5%) patients had normal angiography and 34 
(28.5%) subjects had minimal coronary artery disease 
(MCAD).70 patients were in CAD group of whom 26  
(21.9%)subjects had single coronary artery stenosis (SVD) 
and 44 (36.5%)participants had more than one coronary 
artery stenosis (MCAD). Characteristics of both groups are 
shown in table 1. 
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Table1. Clinical and laboratory characteristics of both groups 
Parameter CAD+ CAD- P-value 
Age (years) 58.30±12.03 54.27±12.80 0.051 
Male/female 42/28(60.1/39.9%) 22/28(44.2/55.8%) 0.008 
Fasting glucose (mg/dL) 100.87±13.50 99.43±13.65 0.377 
BMI (kg/m2) 27.16±4.17 27.11±4.00 0.914 
Total cholesterol (mg/dL) 158.27±38.85 149.76±41.84 0.077 
HDL cholesterol (mg/dL) 44.12±10.83 48.79±14.61 0.002 
Triglycerides (mg/dL) 160.54±93.03 145.82±88.22 0.178 
LDL cholesterol (mg/dL) 82.85±34.67 76.72±39.92 0.166 
Systolic blood pressure (mmHg) 132.22±21.48 130.55±21.32 0.515 
Diastolic blood pressure (mmHg) 80.32±12.67 80.21±10.12 0.939 
White blood cell 7684.88±2422.63 7172.67±2160.02 0.065 
Platelet 233250.00±61781.89 234233.33±59730.30 0.893 
Insulin level (mU/L) 15.56±18.19 13.50±12.91 0.288 
HOMA-IR 3.89±4.63 3.3847±3.50 0.06 
HOMA-IR>2.5 43(61.4%) 23(46%) 0.232 
* Values are presented as mean±SD except where otherwise indicated 
CAD: coronary artery disease. BMI: body mass index. HDL: high density lipoprotein. LDL: low density lipoprotein. 
HOMA-IR: Homeostatis model assessment index of Insulin resistance 
  
Totally, 66 (55%) patients had insulin resistance 
(HOMA-IR> 2.5) and 54 (45%) patients did not have insulin 
resistance. As shown in table 2, the association between 
insulin resistance and coronary artery disease was not 
statistically significant. We also controlled the confounding 
effect such as, age, gender, hypertension and hyperlipidemia, 
using multivariate logistic regression and the same results 
between IR and CAD were obtained.  To evaluate the 
differences of insulin resistance and coronary artery disease 
severity (between four groups including, normal, SV MCAD 
and MVD) using ANOVA test, this difference was not 
statistically significant (P=0.42, F=0.95). In addition, in the 
post hoc tests, no significant difference was found between 
the groups (table 3). 
 
Table 2: Association between insulin resistance and coronary artery disease severity 
P-value MVD*** SVD** MCAD* Normal 
         Severity 
Insulin resistance   
Confounding 
Factors 
0.9 
19 9 19 8 No With 
25 17 15 8 Yes 
0.65 
19 
25 
9 
17 
19 
15 
8 
8 
No 
Yes 
 
Without 
       
Data are presented as number    * MCAD: minimal coronary artery disease   **SVD: single vessel disease   ***MVD: multiple vessel disease 
Table 3: Relationship between insulin resistance and coronary artery disease 
CAD group HOMA-IR F P-value 
Normal 3.10±2.40 
0.95 0.42 
MCAD* 3.50±3.90 
SVD** 3.40±2.80 
MVD*** 4.20±5.40 
Total 3.70±4.20 
Data are expressed as mean±SD     * MCAD: minimal coronary artery disease    **SVD: single vessel disease    ***MVD: multiple vessel disease 
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Discussion 
In this study, 120 non-diabetic cases were evaluated and 
53.5% were males. Although an association was found 
between CAD and IR, more detailed analysis had notable 
findings. For example, the association between CAD and IR 
was found in non-diabetic men. This finding was not 
statistically significant in women. The average age of the 
population was 57.8±12.69 years and 60% of them were 50-
70 years old. This is similar to Karrowni et al.'s study that 
showed the higher prevalence of CAD in the elderly and 
most of the patients were in the same age group (16). 
Although age is an important factor in CAD and IR, Kim et 
al. showed that age increase plays a role in elevating insulin 
resistance (17). In Schmiegelow et al.'s study, insulin 
resistance measures did not improve CVD risk 
discrimination and reclassification in postmenopausal 
women (18). In our study, CAD was more prevalent in 
patients over 70 years, while most IR was seen between 50-
70 years.  
The reason for this finding is that people prone to type II 
diabetes whose disease have not appeared yet are in this 
group and the majority of people older than 70 years and 
with insulin resistance have been excluded from the study. In 
our study, the association between IR and CAD has not been 
achieved in terms of age. Other notable finding in our study 
was that unexpectedly the association between IR and CAD 
was found in normal BMI population which accounts for 
about one third of the patients. However, Karrowni et al. 
whose study was similar to us found no association between 
BMI and insulin resistance (16). Although Schauer et al. had 
a more accurate way of measuring insulin level (3-
phasehyperinsulinemic or euglycemic clamp method) in their 
study. They have achieved similar results and found no 
association between BMI and insulin resistance (19). Insulin 
resistance has pro-atherosclerotic properties. In insulin 
resistance situation, the anti-inflammatory and anti-sclerotic  
properties of NO secreted by the endothelium is inhibited.  
This occurs due to decreasing receptors and change in 
the phosphoinositide 3-kinase pathway (20). 
Although mitogen-activated protein kinase inhibition in 
endothelial cells and smooth muscle decreases the pro-
atherogenic properties, this effect blocks the atherosclerosis 
pathway in mice by starting insulin (21, 22). Moreover, 
insulin receptors are located on monocytes and macrophages 
which promote the process of plaque formation during 
insulin resistance with some intracellular changes (23). In 
addition, reducing spherocytosis cells which collect the 
necrotic cells when necrotic cells increased worsens the 
sclerosis situation (24). Some studies have also mentioned 
the dependence of IR and hs-CRP which indicates 
inflammation deficiency of insulin (25). 
In our study, the most available factor to assess the 
inflammatory role of IR was WBC. This is why we 
evaluated it. The mean WBC was 7471.46±2326.73 and 85% 
of the population were within the normal range and the 
highest IR and CAD rates were seen in this group. No 
association was found between IR and CAD based on WBC. 
To investigate the role of insulin on clotting factors, platelets 
have been used as the most accessible factor. The mean 
platelet level was 233659.73±60832.34 and 92% of the 
patients did not have normal platelet level and the highest IR 
and CAD rates were seen in this group. Varol et al. found 
that the mean platelet volume which is used as an indicator 
of platelet activity increases in patients with CAD in terms of 
insulin resistance (26). This association was not found in our 
study. The association between IR and CAD has been 
reported in the normal PLT category (P=0.04).In our study, 
almost half of the patients had insulin resistance (HOMA-
IR> 2.5) and 58.3% had CAD on angiography. 
The association between IR and atherosclerosis has been 
evaluated in some studies. For example, Karrowni et al. 
examined the association between IR and the extent of 
coronary atherosclerosis determined by angiography in 1073 
non-diabetic post myocardial infarction patients and 
demonstrated an independent association between IR and 
multi-vessel coronary artery disease (16). In Granér et al.’s 
study, patients with more severe degrees of IR had a more 
severe, extensive, and distal types of CAD than patients with 
lower degrees of IR (27). Baseline fasting hyperinsulinemia 
could be a good predictor of significant coronary 
atherosclerosis in non-diabetic patients, which enables a 
more elegant cardio metabolic risk assessment in the setting 
of everyday clinical practice (25). Several large population-
based studies have shown that hyperinsulinemia, a surrogate 
marker for insulin resistance, predicts incident CHD (28-30). 
We neither were able to detect the overall association 
between IR and CAD, nor other studies found this 
association. For example, Vonbank et al. found no difference 
in HOMA-IR between subgroups of 986 consecutive patients 
undergoing elective coronary angiography and were divided 
according to the presence or number of lumen narrowing of 
≥50%, irrespective of diabetes status (31). Accordingly, the 
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lack of a positive association between angiographic CAD 
and HOMA-IR was also reported in an adequately powered 
study and strengthened our negative findings (31). 
Furthermore, a negative result had been previously described 
by Solymoss et al. who related the number of coronary 
arteries with ≥50% stenosis to fasting insulinemia (32). 
Gotoh et al. suggested that IR increases the risk of incident 
CVD through metabolic syndrome (33). 
Though An et al. identified HOMA-IR as an independent 
predictor of one-year coronary atherosclerosis progression in 
CAD patients, however, Gensini score at baseline did not 
correlate to HOMA-IR, which was in agreement with our 
results (34). However, we demonstrated the association 
between insulin resistance and CAD in non-diabetic men in 
our study. This association provides a window that the 
pharmaceutical and behavioral interventions leading to a 
decrease in insulin resistance, may prevent coronary artery 
disease, particularly in high risk patients. For example 
Sugamura et al. suggested that adding Pioglitazone to 
successful statin therapy significantly improves insulin 
resistance and may be an effective therapeutic strategy for 
patients with CAD (35). 
In conclusion, this study although the association was not 
found between insulin resistance and coronary heart disease, 
among men between coronary heart disease and insulin 
resistance, a significant correlation was found. Based on 
these findings, we recommend to rule out coronary heart 
disease in men with insulin resistance. 
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